Ftse Mib
34.888,79
0,09%
DAX
20.405,92
-0,11%
S&P 500
6.051,09
0,00%
NASDAQ
19.926,72
0,12%
Bitcoin
100.870,25
-0,58%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nkarta Inc (NKTX) Nkarta Inc (NKTX) Notizie

NKTX

Nkarta (NKTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NKTX
DataOraFonteTitoloSimboloCompagnia
05/12/202412:01GlobeNewswire Inc.Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2NASDAQ:NKTXNkarta Inc
26/11/202413:02GlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
14/11/202422:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
08/11/202420:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NKTXNkarta Inc
07/11/202422:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
07/11/202422:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
07/11/202422:02GlobeNewswire Inc.Nkarta Reports Third Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/09/202422:01GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
23/08/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/08/202403:03GlobeNewswire Inc.Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
13/08/202422:01GlobeNewswire Inc.Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
31/07/202422:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
24/07/202412:00GlobeNewswire Inc.Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus ErythematosusNASDAQ:NKTXNkarta Inc
16/07/202412:01GlobeNewswire Inc.Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as PresidentNASDAQ:NKTXNkarta Inc
27/06/202412:00GlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
13/06/202422:01GlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
09/05/202422:01GlobeNewswire Inc.Nkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/04/202422:02GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
25/03/202411:30GlobeNewswire Inc.Nkarta Announces Pricing of $240 Million Underwritten OfferingNASDAQ:NKTXNkarta Inc
21/03/202421:01GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
01/03/202422:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NKTXNkarta Inc
09/02/202412:38Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NKTXNkarta Inc
03/01/202422:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NKTXNkarta Inc
10/12/202302:31GlobeNewswire Inc.Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & ExpositionNASDAQ:NKTXNkarta Inc
13/11/202314:25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NKTXNkarta Inc
09/11/202322:02GlobeNewswire Inc.Nkarta Reports Third Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
07/11/202314:02GlobeNewswire Inc.Nkarta to Participate at Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
27/10/202322:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NKTXNkarta Inc
17/10/202318:00Dow Jones NewsNkarta's Stock Climbs 28% After FDA Approves Drug ApplicationNASDAQ:NKTXNkarta Inc
17/10/202317:47PR Newswire (US)Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus NephritisNASDAQ:NKTXNkarta Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NKTX

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
TIT
Telecom Italia
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
STMMI
ST Microelectronics
BIT
IVG
Iveco Group NV
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network